In vitro studies show 80% cell growth inhibition within 72 hours; in vivo imaging results indicated that LHRH-HA-cys-ADOX/Cy5.5 nanoparticles could accumulate at the tumor site and exert long-lasting anti-tumor effects. The gene discussed is GNRH1; the disease is neoplasm.